BeOne Medicines
ONC
#650
Rank
A$54.93 B
Marketcap
A$485.65
Share price
-2.07%
Change (1 day)
-2.23%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): A$7.13

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$6.74. In 2025 the company made an earnings per share (EPS) of A$3.83 an increase over its 2024 EPS that were of A-$8.75.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$7.1386.32%
2025A$3.83-143.75%
2024A-$8.75
2022A-$27.3328.21%
2021A-$21.32-19.96%
2020A-$26.6420.81%
2019A-$22.0531.52%
2018A-$16.76417.57%
2017A-$3.24-37.16%
2016A-$5.15158.95%
2015A-$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.38-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.33-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA